Cargando…

Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma

The most common cause of primary hyperparathyroidism (PHPT) is a solid parathyroid adenoma. Less than 2% of cases of PHPT are caused by cystic parathyroid adenomas formed from degeneration of pre-existing solid parathyroid adenomas. Cystic parathyroid adenomas are non-functional in over 90% of cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Win, George M, Gusov, Timur, Marium, FNU, Gardner, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481103/
https://www.ncbi.nlm.nih.gov/pubmed/34646632
http://dx.doi.org/10.7759/cureus.17577
_version_ 1784576609741701120
author Win, George M
Gusov, Timur
Marium, FNU
Gardner, Michael J
author_facet Win, George M
Gusov, Timur
Marium, FNU
Gardner, Michael J
author_sort Win, George M
collection PubMed
description The most common cause of primary hyperparathyroidism (PHPT) is a solid parathyroid adenoma. Less than 2% of cases of PHPT are caused by cystic parathyroid adenomas formed from degeneration of pre-existing solid parathyroid adenomas. Cystic parathyroid adenomas are non-functional in over 90% of cases. In this case we describe management of a 56-year-old man with acute-onset polydipsia, polyuria, xerostomia, nausea, and constipation. Serum chemistry upon admission revealed hypercalcemia, hyperparathyroidism, and reduced serum phosphorus. Neck sonogram revealed a predominantly anechoic lesion later confirmed by pathology to be a cystic parathyroid adenoma in the right thyroid lobe. Sestamibi scan did not show uptake in parathyroid gland, and parathyroid hormone (PTH) was elevated in fine-needle aspiration sample. Otolaryngology removed the cystic lesion via surgical excision, which led to normalization of PTH level. This case demonstrates the importance of evaluation of cystic components for PTH levels and if confirmed should be treated as a parathyroid adenoma.
format Online
Article
Text
id pubmed-8481103
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-84811032021-10-12 Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma Win, George M Gusov, Timur Marium, FNU Gardner, Michael J Cureus Endocrinology/Diabetes/Metabolism The most common cause of primary hyperparathyroidism (PHPT) is a solid parathyroid adenoma. Less than 2% of cases of PHPT are caused by cystic parathyroid adenomas formed from degeneration of pre-existing solid parathyroid adenomas. Cystic parathyroid adenomas are non-functional in over 90% of cases. In this case we describe management of a 56-year-old man with acute-onset polydipsia, polyuria, xerostomia, nausea, and constipation. Serum chemistry upon admission revealed hypercalcemia, hyperparathyroidism, and reduced serum phosphorus. Neck sonogram revealed a predominantly anechoic lesion later confirmed by pathology to be a cystic parathyroid adenoma in the right thyroid lobe. Sestamibi scan did not show uptake in parathyroid gland, and parathyroid hormone (PTH) was elevated in fine-needle aspiration sample. Otolaryngology removed the cystic lesion via surgical excision, which led to normalization of PTH level. This case demonstrates the importance of evaluation of cystic components for PTH levels and if confirmed should be treated as a parathyroid adenoma. Cureus 2021-08-30 /pmc/articles/PMC8481103/ /pubmed/34646632 http://dx.doi.org/10.7759/cureus.17577 Text en Copyright © 2021, Win et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Win, George M
Gusov, Timur
Marium, FNU
Gardner, Michael J
Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
title Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
title_full Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
title_fullStr Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
title_full_unstemmed Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
title_short Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
title_sort primary hyperparathyroidism secondary to a sestamibi-negative cystic parathyroid adenoma
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481103/
https://www.ncbi.nlm.nih.gov/pubmed/34646632
http://dx.doi.org/10.7759/cureus.17577
work_keys_str_mv AT wingeorgem primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma
AT gusovtimur primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma
AT mariumfnu primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma
AT gardnermichaelj primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma